Weekly Digest Archive

Insider Buying and Congress Trades, Week of Aug 2 to Aug 9, 2026

100 open-market insider buys of $50,000 or more ($23.9B in total), 144 Congress trades disclosed, and 34 of our calls graded (22 right). Rebuilt after the fact from the same filings the free Sunday email now draws on; no email went out this week, the digest launched later.

Biggest insider buys, Aug 2 to Aug 9 (100 filings, $23.9B total)

$REBNLim Jung Jae, CEO and Interim CFO$23.6B
$APCXLORD ALBERT L, Director$115.9M
$BRVEForbion Growth Opportunities Fund III Cooperatief U.A., 10% owner · 6 insiders this week$64.8M
$EWAVSpace Summit Capital LLC, Insider$10.9M
$ATTORedmile Group, LLC, 10% owner · 3 insiders this week$10.2M
$ATTOFrazier Life Sciences XI, L.P., 10% owner · 3 insiders this week$10.0M
$BSXMahoney Michael F, Chairman, President & CEO · 3 insiders this week$9.0M
$ATTOSanofi, 10% owner · 3 insiders this week$5.1M

Largest Congress trades disclosed this week (144 trades)

$BWXTBUYRep. April McClain Delaney$15,001 - $50,000
$CHRWBUYRep. April McClain Delaney$15,001 - $50,000
$CHRWBUYRep. April McClain Delaney$15,001 - $50,000
$HUBBBUYRep. April McClain Delaney$15,001 - $50,000
$FWONKBUYRep. April McClain Delaney$15,001 - $50,000
$FWONKBUYRep. April McClain Delaney$15,001 - $50,000
$FWONKBUYRep. April McClain Delaney$15,001 - $50,000
$FWONKBUYRep. April McClain Delaney$15,001 - $50,000

Calls graded this week (22 of 34 right, 68% running record)

$SCTXBULLISHAvoro buys $36.3M of Scribe Therapeutics after selloffHIT +26.0%
$ARTVBULLISHRA Capital cluster buys Artiva Biotherapeutics sharesHIT +21.6%
$ARTVBULLISHRA Capital buys $1.4M more of Artiva BiotherapeuticsHIT +21.4%
$BOLDBULLISHTang Capital adds to Boundless Bio stake againHIT +14.5%
$HUTBEARISHHut 8 misses estimates, posts wider lossHIT +14.2%

Get next week’s in your inbox

One free email every Sunday. No card, unsubscribe in one click.

Figures are computed from SEC Form 4 filings, STOCK Act disclosures, and InsiderWatch’s own graded alert ledger as of the week’s end. Congress amounts are the disclosed ranges. Graded calls are hypothetical, close-to-close, and exclude fees; the full ledger with misses is on the track record. Not investment advice.